Top Stories
The PCR assay is designed to distinguish between bacterial vaginosis and Candida vaginitis, conditions with overlapping symptoms that can be misdiagnosed.
The Cambridge startup's handheld device analyses carbon dioxide during relaxed breathing, offering clinics a faster alternative to specialist-run spirometry.
The AI company highlighted rising demand for health-related queries and improved model performance.
The new model links payment to clinical outcomes and total cost of care improvements.
The agency's TEMPO pilot aims to speed up access to digital health technologies for chronic diseases while safeguarding patient safety.
Conference News
Beta-site engagement begins as Pictor introduces an integrated 96-well workflow designed for scalable targeted protein analysis in research laboratories.CARLSBAD, Calif., July 27, 2026 /PRNewswire/ --...
Key facts:Thermo Fisher’s specialty diagnostics portfolio addresses high-impact clinical needs across multiple myeloma monitoring with the EXENT® Solution, community oncology testing, critical care, a...
Presentation to feature first-in-human results for ISM6331, a novel, AI-designed pan-TEAD inhibitor targeting the Hippo pathwayGlobal Phase 1 multicenter study evaluates safety, tolerability, and prel...
Company debuts single-use, cartridge-based platform at ADLM 2026 in Anaheim, extending its label-free kinetics technology from the research bench to bedside diagnostics27-Jul-2026 at 4:35 AM EDT, by A...
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN ...
